SECFilings.com Examines Innovus Pharmaceuticals' (INNV) Position in Multi-Billion Dollar Female Sexual Dysfunction Market
Wally Klemp, with Moleculin Biotech, Inc. (MBRX), discusses on Uptick Network their new treatment for Second-Line Leukemia Patients
Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ with the Indian FDA (Directorate General of Health Services) by its Partner Khandelwal Laboratories
Innovus Pharma to Request Regulatory Guidance for Filing for its FlutiCare™ Product in Europe for the Treatment of Allergic Rhinitis
Innovus Pharma Achieves Major Milestone with Securing a Manufacturing Agreement for FlutiCare™ in Anticipation of the FDA Decision
Innovus Pharma Signs Exclusive License and Distribution Agreement with BroadMed for EjectDelay®in Lebanon
Available RSS Feeds: Available RSS Feeds: